NCT05234112Completed
Prevention and Screening Towards Elimination of Cervical Cancer
Prevention and Screening Intervention Project - Towards Elimination of Cervical Cancer
Source: ClinicalTrials.gov · Last updated 22 Feb 2024
Brief summary (registry, in English)
The research project applies the protocol of the World Health Organisation for screening of cervical cancer, with testing of hrHPV as first screening, followed by Visual Inspection of the cervix with Acetic Acid for hrHPV-positive women and for women with minor lesions thermo-ablation of affected areas. This procedure is applied in Uganda, India and Bangladesh. In Slovakia hrHPV-positive women are offered Pap-smear and for women with Pap IV lis excision.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30000 (actual)
- First submitted
- 3 Jan 2022
- Start date
- 15 Sept 2022
- Primary completion date
- 30 Dec 2023
- Lead sponsor
- University Medical Center Groningen
- Diseases
- Cervical cancer
- NCT number
- NCT05234112
What you commit to
- Study type: Interventional
- Participants enrolled: 30000
- From 15 Sept 2022 to the primary completion date, 30 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Clinical signs of cervical carcinoma
- Menstruation or other vaginal blood loss
Who the study is looking for
- Female in eligible age group
- Ability to give informed consent and participate in study
Age in the registry: 30 years to 60 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mpasana Coordinator of this site? Confirm its status | Kakumiro | Uganda | Unknown status |
Related publications
- Applying an AI Decision Support Device During Cervical Cancer Screening in Bangladesh and Uganda: Implementation Study.JMIR Form Res · 2026 · PMID 42691425
- Cervical high-risk human papillomavirus infection and its associated risk factors: a community-based cross-sectional study in hard-to-reach areas in Bangladesh.BMJ Open · 2025 · PMID 41412622
This page is information, not medical advice. Discuss any trial with your doctor.